Work

P45.16 Adverse Event Burden of Oral Tyrosine Kinase Inhibitors in EGFR and ALK Metastatic Non-Small Cell Lung Cancer

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.484

Authors: D. Riley, N. Kaur, A. Baglione, R. Hall, L. Barnes, R. Gentzler

Institutions: University of Virginia Cancer Center, University of Virginia

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3205062170

Cites:

Cited by:

Related to: 10